AGP Executive Report
Last update: 5 hours agoMedical Cannabis & Sleep: A Cochrane review says current research is too weak to show whether medical cannabis improves insomnia, sleep quality or daytime functioning. Product Compliance: Cannabis brands can face legal and regulatory trouble after lab testing, with packaging, advertising, social media and budtender claims all posing risks. Safety & Rules: The American Medical Association is urging FDA safety standards for botanical products, including cannabis. Oklahoma’s new edible rules took effect Nov. 1, while New York officials warned families to lock edibles away from Halloween treats. Hemp Policy: A federal ban on synthetic hemp cannabinoids is set to take effect Nov. 12, as hemp businesses look for a legislative reprieve.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.